Cencora, Inc.
COR Healthcare Medical Distribution
Cencora, Inc.’s revenue for fiscal 2025 (year ended September 2025) was $321.3 billion, up 9.31% from fiscal 2024. In the quarter to June 2026, revenue grew 5.07%, EPS grew 11.3%, free cash flow grew 3,385.3% and total debt rose 42.3%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for three consecutive years, revenue growth for ten; insiders bought in the last twelve months.
Follow COR
Cencora, Inc. 10-K filed Nov 25, 2025
What changed
Item 7, Management’s Discussion and Analysis, against the 10-K filed Nov 26, 2024: 16 added · 12 removed · 67 modified; 17 with only figures updated; 2 moved without change
95 more changes in this Item, word by word, in Powerpack.
Powerpack